By Pete Johnson Over the course of the past year and a half, investors have been more focused on adding pharmaceutical stocks to bolster their portfolios. This comes as several large-cap pharma stocks have dominated the news as they raced to develop an effective vaccine for COVID-19.
Big-name pharmaceutical companies, including Pfizer (NYSE: PFE), Moderna (NASDAQ: MRNA), and Johnson & Johnson (NYSE: JNJ) that successfully developed a vaccine, have now become household names if they weren’t already.
Besides the COVID-19 vaccine, there are some pretty incredible innovations happening in the pharmaceutical industry. These stocks have the possibility of generating substantial earnings for shareholders. Let’s take …read more
